农业百科

RNAV8 Bio (pronounced Renovate Bio) has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) for PROPEL (Programmable RNA for Optimal Precision in Therapeutic Efficacy and Localization).

France-based Clean Cells launched its next-generation sequencing (NGS)-based safety testing for viral matrices, such as viral vectors and recombinant preparations. The company also announced that it had acquired French bioinformatics CRO Xegen, which specializes in NGS data analysis.

Biotech company Moonwalk Biosciences announced that it has raised $70 million from an oversubscribed series B financing round. The company plans to use the funds to continue developing its adipose-targeted RNAi therapies for obesity and cardiometabolic conditions. 

Clear, sparkling drinks are leading the next wave of the protein craze.Consumers want options that don’t feel as dense or heavy as protein shakes. Vy Cutting was one of them.

The role of artificial intelligence (AI) in ingredient discovery is becoming increasingly prominent, with the technology significantly cutting the timelines and costs associated with such research.

K-beauty is growing away from a trend-based category into a global innovation model for the personal care industry. The category’s rapid spread has raised expectations around ingredient transparency, product efficacy, and an enjoyable sensorial experience during daily routines. 

Elissara, a nutricosmetic by Monteloeder, was found to exhibit multifactorial activity associated with healthy hair and follicle function. According to a preclinical study examining scalp and hair growth, the four-botanical polyphenol-enriched ingredients featured in Elissara demonstrated support of hair follicle function and resilience.

BrainChild Bio has raised a $116 million Series A financing, the proceeds of which will, in part, fund the pivotal registrational trial to assess its lead candidate, an autologous chimeric antigen receptor (CAR) T cell therapy being developed to treat a rare and aggressive pediatric brainstem tumor whose current standard of care consists of radiation.

Zoom in: The programme, called AI4CancerCure.NRW, launched Sept. 4 by state premier Hendrik Wüst and science minister Ina Brandes, aims to use artificial intelligence across cancer research and care, from cancer biology and data-driven drug design to imaging, prevention, early detection and personalised treatment.